Associate Professor
University of Genova, Italy
Malgorzata Mikulska is Associate Professor of Infectious Diseases at the University of Genova (Department of Health Sciences, DISSAL) since 2015, and full time Infectious Diseases Consultant at the Division of Infectious Diseases, IRCCSS Ospedale Policlinico San Martino in Genova, Italy.
She obtained her medical degree at Warsaw Medical University, Poland, subsequently recognized in 2005 by the University of Genova. She completed her specialty training in Infectious Diseases at the University of Genova and obtained PhD degree at Università Cattolica di Roma, Italy.
She is an author or co-author of over 250 documents, mostly indexed in international medical journals, with H-index of 49. She is also a co-author of 10 book chapters, including the one of Prophylaxis and Empirical Therapy of Infections in Cancer Patients in “Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases”, 9th Edition. By John E. Bennett, Raphael Dolin, Martin J. Blaser. Elsevier 2020.
Her principal areas of expertise are infections in the immunocompromised patients, in particular in patients with haematological disorders and allogeneic haematopoietic stem cell transplant (HSCT) recipients, and diagnosis and treatment of invasive fungal infections.
She is an active member of the following scientific societies:
• President Elect of the International Council of Immunocompromised Host Society (ICHS)
• Infectious Diseases Working Party (IDWP) of EBMT (The European Group for Blood and Marrow Transplantation), Secretary for years 2016-2020
• European Conference on Infections in Leukemia (ECIL) group since 2009
• European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
o Infectious Diseases Member of Professional Affaires Committee (PAS) of ESCMID
o ESCMID Study Group for Infections in Compromised Hosts (ESGICH)
o ESCMID Fungal Infection Study Group Study Group (EFISG)
• Academy Committee of ECMM (European Confederation of Medical Mycology) and ECCM Fellow since 2016
• Italian society of Infectious diseases and Tropical Medicine (SIMIT)
• Italian Federation of Human and animal Mycopathology (FIMUA) since 2008
Disclosure(s): AlloVir: Advisor/Consultant (Terminated, June 30, 2023); Gilead: Grant/Research Support (Ongoing), Honoraria (Ongoing); Janssen: Honoraria (Ongoing); Moderna: Honoraria (Terminated, September 16, 2023); Mundipharma: Advisor/Consultant (Ongoing), Honoraria (Ongoing); Pfizer, Inc.: Honoraria (Terminated, April 14, 2024); Shionogi: Honoraria (Terminated, December 2, 2023)
25 - Managing Infection in the Era of MDR, XDR and PDR Among Immunocompromised Hosts
Thursday, October 17, 2024
10:30 AM – 11:45 AM US PT
72 - Quinolone prophylaxis: a double-edged sword?
Thursday, October 17, 2024
11:20 AM – 11:45 AM US PT